相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Stress fractures in systemic lupus erythematosus after long-term MTX use successfully treated by MTX discontinuation and individualized bone-specific therapy
T. Rolvien et al.
LUPUS (2019)
Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up
M. A. Png et al.
OSTEOPOROSIS INTERNATIONAL (2019)
High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan
Hiroe Sato et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study
S. -J. Lim et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Location of fractures and the characteristics of patients with atypical femoral fractures: analyses of 38 Japanese cases
Kojiro Hyodo et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2017)
Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis
Seiya Ota et al.
BREAST CANCER (2017)
Screening for Atypical Femur Fractures Using Extended Femur Scans by DXA
Denise M. van de laarschot et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates
H. Sato et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center
J. H. Koh et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients
Naoki Kondo et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates
H. Sato et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Factors associated with atypical femoral fracture
Dam Kim et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Brief Report: Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study
Jung Hee Koh et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
Robert A. Adler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
The incidence of and risk factors for developing atypical femoral fractures in Japan
Yoshitomo Saita et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2015)
The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment
Yoshitomo Saita et al.
BONE (2014)
Absence of femoral cortical thickening in long-term bisphosphonate users: Implications for atypical femur fractures
Foster Chen et al.
BONE (2014)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls
Jorg Schilcher et al.
BONE (2013)
Incomplete Atypical Femoral Fractures: Assessing the Diagnostic Utility of DXA by Extending Femur Length
Malachi J. McKenna et al.
JOURNAL OF CLINICAL DENSITOMETRY (2013)
Frequency of Incomplete Atypical Femoral Fractures in Asymptomatic Patients on Long-Term Bisphosphonate Therapy
Renata La Rocca Vieira et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Incidence and demography of femur fractures with and without atypical features
Adrianne C. Feldstein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Comparison of Disease Activity Score (DAS) 28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values
Eisuke Inoue et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Bisphosphonate therapy in rheumatoid arthritis
Veronique Breuil et al.
JOINT BONE SPINE (2006)